Understanding how lung cells contribute to inflammation and scarring in the lungs
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis
This study is looking at how certain lung cells work together during inflammation and scarring in the lungs, which could help us find new ways to treat lung diseases that cause these problems, so patients can have better options for managing their conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11055283 on NIH RePORTER |
What this research studies
This research investigates the roles of specific lung cells, namely alveolar macrophages and fibroblasts, in the processes of inflammation and fibrosis in the lungs. The study aims to explore how these cells communicate and regulate each other, particularly focusing on the secretion of signaling molecules that can influence inflammatory responses. By examining the mechanisms of these interactions, the research seeks to identify potential therapeutic targets for treating lung diseases characterized by excessive inflammation and scarring. Patients may benefit from insights gained into how lung conditions develop and progress, potentially leading to new treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from chronic lung diseases characterized by inflammation and fibrosis, such as asthma or pulmonary fibrosis.
Not a fit: Patients with acute lung infections or those without chronic lung conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that improve outcomes for patients with lung inflammation and fibrosis.
How similar studies have performed: Previous research has shown promising results in understanding the roles of lung macrophages and fibroblasts in lung diseases, indicating that this approach has potential for significant advancements.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Peters-Golden, Marc L — University of Michigan at Ann Arbor
- Study coordinator: Peters-Golden, Marc L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.